Management of atrial fibrillation in patients with heart failure

被引:31
作者
Efremidis, Michael
Pappas, Loukas
Sideris, Anthony
Filippatos, Gerasimos
机构
[1] Athens Univ Hosp, Attikon 11523, Ambelokipi Athe, Greece
[2] Evangelismos Gen Hosp, Athens, Greece
关键词
atrial fibrillation; heart failure; rhythm control; rate control; antiarrhythmic drugs; ablation; cardiac resynchronization therapy;
D O I
10.1016/j.cardfail.2007.10.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: There is a well-documented relationship and a complex interaction between atrial fibrillation (AF) and heart failure. The coexistence of these 2 clinical entities renders their management even more challenging. Methods and results: We searched current literature to review the management of AF in patients with heart failure. The cornerstones of AF treatment are rate control, cardioversion, and maintenance of sinus rhythm (SR), and prevention of thromboembolism. The issue of rhythm versus rate control remains unresolved. Nonpharmacologic therapies such as radiolfrequency catheter ablation of the atrioventricular node with permanent pacemaker implantation, curative catheter ablation of AF, and cardiac resynchronization therapy are emerging and may alter the management of these patients. Conclusion: Treatment of atrial fibrillation in the setting of heart failure encompasses a variety of approaches including drugs, devices, and ablation. Larger randomized trials are required to clarify the management of such patients.
引用
收藏
页码:232 / 237
页数:6
相关论文
共 69 条
[41]   Long-term benefits of biventricular pacing in congestive heart failure: Results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study [J].
Linde, C ;
Leclercq, C ;
Rex, S ;
Garrigue, S ;
Lavergne, T ;
Cazeau, S ;
McKenna, W ;
Fitzgerald, M ;
Deharo, JC ;
Alonso, C ;
Walker, S ;
Braunschweig, F ;
Bailleul, C ;
Daubert, JC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (01) :111-118
[42]   Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation a prospective and randomized study [J].
Madrid, AH ;
Bueno, MG ;
Rebollo, JMG ;
Marín, I ;
Peña, G ;
Bernal, E ;
Rodriguez, A ;
Cano, L ;
Cano, JM ;
Cabeza, P ;
Moro, C .
CIRCULATION, 2002, 106 (03) :331-336
[43]   The role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases:: Meta-analysis of randomized controlled clinical trials [J].
Madrid, AH ;
Peng, J ;
Zamora, J ;
Marín, I ;
Bernal, E ;
Escobar, C ;
Muños-Tinoco, C ;
Rebollo, JMG ;
Moro, C .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2004, 27 (10) :1405-1410
[44]   Valsartan reduces the incidence of atrial fibrillation in patients with heart failure:: Results from the Valsartan Heart Failure Trial (Val-HeFT) [J].
Maggioni, AP ;
Latini, R ;
Carson, PE ;
Singh, SN ;
Barlera, S ;
Glazer, R ;
Masson, S ;
Cerè, E ;
Tognoni, G ;
Cohn, JN .
AMERICAN HEART JOURNAL, 2005, 149 (03) :548-557
[45]   Atrial fibrilation in heart failure: Epidemiology, pathophysiology, and rationale for therapy [J].
Maisel, WH ;
Stevenson, LW .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (6A) :2D-8D
[46]   AMIODARONE AND TORSADES-DE-POINTES IN PATIENTS WITH ADVANCED HEART-FAILURE [J].
MIDDLEKAUFF, HR ;
STEVENSON, WG ;
SAXON, LA ;
STEVENSON, LW .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (07) :499-502
[47]   Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation [J].
Molhoek, SG ;
Bax, JJ ;
Bleeker, GB ;
Boersma, E ;
van Erven, L ;
Steendijk, P ;
van der Wall, EE .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (12) :1506-1509
[48]   Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM [J].
Murray, KT ;
Rottman, JN ;
Arbogast, PG ;
Shemanski, L ;
Primm, RK ;
Campbell, WB ;
Solomon, AJ ;
Olgin, JE ;
Wilson, MJ ;
DiMarco, JP ;
Beckman, KJ ;
Dennish, G ;
Naccarelli, GV ;
Ray, WA .
HEART RHYTHM, 2004, 1 (06) :669-675
[49]  
Nieminen MS, 2005, EUR HEART J, V26, P384
[50]   TACHYCARDIA-INDUCED CARDIOMYOPATHY - A REVERSIBLE FORM OF LEFT-VENTRICULAR DYSFUNCTION [J].
PACKER, DL ;
BARDY, GH ;
WORLEY, SJ ;
SMITH, MS ;
COBB, FR ;
COLEMAN, RE ;
GALLAGHER, JJ ;
GERMAN, LD .
AMERICAN JOURNAL OF CARDIOLOGY, 1986, 57 (08) :563-570